A majority of Israel's publicly-traded biotechnology companies will be forced to halt their research and development activities in as little as two-and-a-half years if they do not alter their business strategies immediately, research company Dun & Bradstreet Israel warned on Sunday.
click below to see the whole article...
http://www.jpost.com/servlet/Satellite?cid=1191257247480&pagename=JPost%2FJPArticle%2FShowFull
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment